Evidence-Based Benefits
- Heart failure — the Q-SYMBIO trial (Mortensen et al., 2014) — a landmark multicenter RCT of 420 patients — found CoQ10 (100 mg TID) reduced cardiovascular mortality by 43%, all-cause mortality by 42%, and improved NYHA functional class
- Statin side effects — statins inhibit the mevalonate pathway that produces both cholesterol and CoQ10; supplementation at 100-200 mg/day may reduce statin-associated myalgia in some patients (Caso et al., 2007)
- Exercise performance — Cooke et al. (2008) found CoQ10 supplementation increased time to exhaustion and reduced subjective fatigue during cycling, though effects were more pronounced in older or less-trained subjects
- Antioxidant protection — CoQ10 (as ubiquinol) is one of the most potent lipid-soluble antioxidants, protecting cell membranes and LDL cholesterol from oxidation